House Energy & Commerce committee chair Frank Pallone (D-NJ) (Kevin Dietsch/Pool via AP Images)
September 27, 2022 08:53 AM EDTUpdated 10:30 AM
FDA+

Com­plete­ly clean FDA-in­dus­try user fee deal at­tached to a must-pass gov­ern­ment spend­ing bill

Zachary Brennan

Senior Editor

With four days left in the fis­cal year, FDA-re­lat­ed pol­i­cy rid­ers ap­proved in both House and Sen­ate com­mit­tees, at least for now, ap­pear dead, ac­cord­ing …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Trump says he'll sign or­der on 'most fa­vored na­tion' drug price plans Mon­day

Lil­ly says fur­ther head-to-head tri­al da­ta back Zep­bound over No­vo’s We­govy

Lil­ly shuf­fles key ex­ec­u­tive po­si­tions; Mikael Dol­sten takes an­oth­er post-Pfiz­er as­sign­ment

From deal to dis­as­ter: Drug­mak­ers face a changed Wash­ing­ton as Trump em­braces ‘most fa­vored na­tion’ prices

Rev­o­lu­tion’s KRAS drugs ap­pear com­pet­i­tive in sev­er­al lung can­cer set­tings

Io­vance stock plum­mets af­ter low­ered full-year guid­ance, missed an­a­lyst ex­pec­ta­tions for Am­tagvi

A service from the Financial Times